SGAM
GEVA

Smith Group Asset Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Smith Group Asset Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-20,531
Closed -$862K – 465
2013
Q2 		$862K Buy
+20,531
New +$862K 0.04% 189